Should Mondelez’s Stronger Q2 Results, Recall and Chocolate Innovation Require Action From Mondelez (MDLZ) Investors?

• Mondelez International recently reported second-quarter 2026 results showing higher sales of US$9,355 million and higher net income of US$1,548 million year on year, alongside an ongoing share buyback and a nationwide recall of Cadbury Dairy Milk Oreo Candy bars in the US due to undeclared pistachio allergens.
• At the same time, the company is using innovation such as cell‑cultured chocolate technology and limited‑edition CHIPS AHOY! Mystery Cookies to respond to cocoa cost volatility and keep consumers engaged while it addresses food safety risks.
• We’ll now examine how Mondelez’s stronger earnings and product innovation, including cell‑cultured chocolate, may influence the existing investment narrative.

Outshine the giants: these 16 early-stage AI stocks could fund your retirement.

Mondelez International Investment Narrative Recap

To own Mondelez International, you generally need to believe in its ability to grow global snack brands while managing input costs and protecting margins. The latest quarter’s higher sales and net income support that narrative, while the Cadbury recall highlights food safety as a key operational risk, but it does not appear to materially change the main short term catalyst of pricing and product mix supporting earnings.

The Q2 2026 earnings announcement, with net income of US$1,548 million on sales of US$9,355 million, is most relevant here, as it shows the company generating higher profits while continuing share buybacks. Against the backdrop of elevated cocoa costs and recent innovation around cell cultured chocolate and limited edition launches, these results give investors more context on how current initiatives are flowing through to the income statement.

Yet while earnings improved, the recall underlines a food safety and brand trust risk that investors should be aware of as they consider...

Read the full narrative on Mondelez International (it's free!)

Mondelez International's narrative projects $43.1 billion revenue and $4.7 billion earnings by 2029. This requires 2.8% yearly revenue growth and a roughly $1.2 billion earnings increase from $3.5 billion today.

Uncover how Mondelez International's forecasts yield a $68.86 fair value, a 11% upside to its current price.

Exploring Other Perspectives

Three Simply Wall St Community fair value estimates for Mondelez range from US$68.86 to US$109.98, showing how far apart individual views can be. As you compare those to your own work, remember that recent margin sensitivity to cocoa costs and pricing remains central to how the business might perform over time.

Explore 3 other fair value estimates on Mondelez International - why the stock might be worth as much as 77% more than the current price!

Form Your Own Verdict

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your Mondelez International research is our analysis highlighting 3 key rewards and 1 important warning sign that could impact your investment decision.
• Our free Mondelez International research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Mondelez International's overall financial health at a glance.

Contemplating Other Strategies?

Every day counts. These free picks are already gaining attention. See them before the crowd does:

• Invest in the nuclear renaissance through our list of 88 elite nuclear energy infrastructure plays powering the global AI revolution.
• We've uncovered the 9 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.
• AI is about to change healthcare. These 41 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com